Treace Medical Concepts (TMCI) Revenue & Revenue Breakdown
Treace Medical Concepts Revenue Highlights
Latest Revenue (Y)
$209.36M
Latest Revenue (Q)
$68.71M
Treace Medical Concepts Revenue by Period
Treace Medical Concepts Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | $209.36M | 11.89% |
2023-12-31 | $187.12M | 31.92% |
2022-12-31 | $141.84M | 50.22% |
2021-12-31 | $94.42M | 64.59% |
2020-12-31 | $57.37M | 45.54% |
2019-12-31 | $39.42M | - |
Treace Medical Concepts generated $209.36M in revenue during NA 2024, up 11.89% compared to the previous quarter, and up 531.15% compared to the same period a year ago.
Treace Medical Concepts Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-12-31 | $68.71M | 52.39% |
2024-09-30 | $45.09M | 1.42% |
2024-06-30 | $44.45M | -13.02% |
2024-03-31 | $51.11M | -17.85% |
2023-12-31 | $62.21M | 52.64% |
2023-09-30 | $40.76M | -2.85% |
2023-06-30 | $41.95M | -0.57% |
2023-03-31 | $42.20M | -15.22% |
2022-12-31 | $49.77M | 50.56% |
2022-09-30 | $33.05M | 10.30% |
2022-06-30 | $29.97M | 3.17% |
2022-03-31 | $29.05M | -13.13% |
2021-12-31 | $33.44M | 54.67% |
2021-09-30 | $21.62M | 4.67% |
2021-06-30 | $20.65M | 10.41% |
2021-03-31 | $18.71M | -22.39% |
2020-12-31 | $24.11M | 68.97% |
2020-09-30 | $14.27M | 84.34% |
2020-06-30 | $7.74M | -31.25% |
2020-03-31 | $11.26M | - |
Treace Medical Concepts generated $68.71M in revenue during Q4 2024, up 52.39% compared to the previous quarter, and up 168.58% compared to the same period a year ago.
Treace Medical Concepts Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
VREX | Varex Imaging | $811.00M | $199.80M |
TMCI | Treace Medical Concepts | $209.36M | $68.71M |
KIDS | OrthoPediatrics | $204.73M | $52.67M |
SIBN | SI-BONE | $167.18M | $49.00M |
CTKB | Cytek Biosciences | $111.11M | $57.48M |
AKYA | Akoya Biosciences | $81.67M | $16.64M |
SGHT | Sight Sciences | $79.87M | $19.07M |
DSGN | Design Therapeutics | - | - |
TRML | Tourmaline Bio | - | - |